News

Landmark trial expands genomic screening options for enrolling patients

180 of us in DC to advocate for cancer research and patients

Sending SWOGGIES a selected publication each week with high-value information

27 editions of our flagship training course = huge impact

The S2212 de-escalation trial asks important questions the NCI's NCTN is uniquely qualified to answer

GU investigator Dr. Parminder Singh leads second team to tackle the Tour de Scottsdale.

The next installment of our signature webinar will be March 26th